These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23587001)

  • 1. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
    J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.
    Cojocaru V; Winn PJ; Wade RC
    Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do substrates enter and products exit the buried active site of cytochrome P450cam? 2. Steered molecular dynamics and adiabatic mapping of substrate pathways.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):813-30. PubMed ID: 11061977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment.
    Fischer A; Smieško M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of CYP51: implications for function and inhibitor design.
    Yu X; Cojocaru V; Mustafa G; Salo-Ahen OM; Lepesheva GI; Wade RC
    J Mol Recognit; 2015 Feb; 28(2):59-73. PubMed ID: 25601796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?
    Schleinkofer K; Sudarko ; Winn PJ; Lüdemann SK; Wade RC
    EMBO Rep; 2005 Jun; 6(6):584-9. PubMed ID: 16028306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 structure-function: insights from molecular dynamics simulations.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Rev; 2016 Aug; 48(3):434-52. PubMed ID: 27167388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires.
    Hays AM; Dunn AR; Chiu R; Gray HB; Stout CD; Goodin DB
    J Mol Biol; 2004 Nov; 344(2):455-69. PubMed ID: 15522298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design.
    Yu X; Nandekar P; Mustafa G; Cojocaru V; Lepesheva GI; Wade RC
    Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):67-78. PubMed ID: 26493722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.
    Clodfelter KH; Waxman DJ; Vajda S
    Biochemistry; 2006 Aug; 45(31):9393-407. PubMed ID: 16878974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and properties of CYP231A2 from the thermoacidophilic archaeon Picrophilus torridus.
    Ho WW; Li H; Nishida CR; de Montellano PR; Poulos TL
    Biochemistry; 2008 Feb; 47(7):2071-9. PubMed ID: 18197710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
    Basudhar D; Madrona Y; Kandel S; Lampe JN; Nishida CR; de Montellano PR
    J Biol Chem; 2015 Apr; 290(16):10000-17. PubMed ID: 25670859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.
    Gay SC; Roberts AG; Halpert JR
    Future Med Chem; 2010 Sep; 2(9):1451-68. PubMed ID: 21103389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of active site access channels in cytochromes P450.
    Wade RC; Winn PJ; Schlichting I; Sudarko
    J Inorg Biochem; 2004 Jul; 98(7):1175-82. PubMed ID: 15219983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior of human cytochromes P450 on lipid membranes.
    Berka K; Paloncýová M; Anzenbacher P; Otyepka M
    J Phys Chem B; 2013 Oct; 117(39):11556-64. PubMed ID: 23987570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B; Chow D; Hu M
    Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.